Boned Frederic
Known title: SVP/GM, Human Nutri. & HealthCIK: 0001953220
Associated companies
Transaction History
| BCPC | ▼ Sell | Tax Withholding | 203 | $36K | 2/12/2026 | View on chart |
| BCPC | ▲ Buy | Grant | 2,870 | $0 | 2/11/2026 | View on chart |
| BCPC | ▲ Buy | Grant | 2,247 | $0 | 2/11/2026 | View on chart |
| BCPC | ▼ Sell | Tax Withholding | 1,151 | $206K | 2/11/2026 | View on chart |
| BCPC | ▼ Sell | Tax Withholding | 430 | $74K | 2/8/2026 | View on chart |
| BCPC | ▼ Sell | Tax Withholding | 1,085 | $166K | 10/31/2025 | View on chart |
| BCPC | ▲ Buy | Grant | 1,580 | $0 | 2/12/2025 | View on chart |
| BCPC | ▲ Buy | Grant | 1,380 | $0 | 2/8/2024 | View on chart |
| BCPC | ▲ Buy | Grant | 770 | $0 | 2/8/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 26, 2026
Balchem (BCPC) Seen Trading Below Fair Value
A recent Yahoo analysis notes that BCPC is priced below its estimated fair value. The comment highlights a possible valuation gap while the stock sits near a long‑standing support level. This context may be useful for investors reviewing the company's current price relative to its fundamentals.
Balchem (BCPC) Seen Trading Below Fair Value. A recent Yahoo analysis notes that BCPC is priced below its estimated fair value. The comment highlights a possible valuation gap while the stock sits near a long‑standing support level. This context may be useful for investors reviewing the company's current price relative to its fundamentals.